류덕희

류덕희, listed as board member, appears in our data through filings on 경동제약 shares, published by DART (FSS). In total, 35 filings cover trades dated from 8 March 2021 to 8 October 2026.

No open-market sale appears; the market trades are 34 purchases worth €3,540. The totals exclude 33 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 4 purchases and no sales.

None of the 27 purchases we analysed coincided with buying by another insider of the same company within 30 days.

Most recently, on 8 October 2026, the filings show a transaction in 경동제약. The clock since the last published purchase (14 July 2026) now reads 96 days. Filings reach the DART (FSS) feed a median of 6 days after the trade. This delay matters because a trade only becomes useful information once it is public. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.